Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Achilles Therapeutics plc from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Achilles Therapeutics plc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q4 2021 to Q4 2023.
  • Achilles Therapeutics plc Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2023 was $1.1M, a 67% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.1M -$2.23M -67% 31 Dec 2023 20-F 04 Apr 2024
Q2 2023 $1.86M 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $3.33M -$991K -22.9% 31 Dec 2022 20-F 07 Mar 2023
Q4 2021 $4.32M 31 Dec 2021 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.